Nanodrug delivery systems and cancer stem cells: From delivery carriers to treatment

被引:12
作者
Yan, Jianqin [1 ]
Long, Xuehua [1 ]
Liang, Yan [1 ]
Li, Fashun [1 ]
Yu, Hongli [1 ]
Li, Yifei [1 ]
Li, Zhipeng [1 ]
Tian, Yu [1 ]
He, Bin [2 ,3 ]
Sun, Yong [1 ]
机构
[1] Qingdao Univ, Sch Pharm, Dept Pharmaceut, Qingdao 266021, Peoples R China
[2] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China
[3] Sichuan Univ, Sch Biomed Engn, Chengdu 610064, Peoples R China
基金
中国博士后科学基金;
关键词
Cancer stem cell; Nanodrug delivery systems; Targeting strategies; Cancer therapy; BREAST-CANCER; EXTRACELLULAR VESICLES; PHOTODYNAMIC THERAPY; INITIATING CELLS; DRUG-RESISTANCE; TUMOR-GROWTH; NANOPARTICLES; TARGET; GLIOBLASTOMA; INHIBITION;
D O I
10.1016/j.colsurfb.2022.112701
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Cancer stem cells (CSCs) control tumor occurrence and development, chemotherapy tolerance, and cancer recurrence and metastasis due to their characteristics of high proliferation, self-renewal, multidirectional dif-ferentiation, high tumorigenicity, and multiple drug resistance. Therefore, effective elimination of CSCs is the key to improving the efficacy of cancer therapy. Due to their small size, good biocompatibility, multi-drug co -delivery, and many other advantages, nanocarriers are often used for targeted drug delivery to achieve efficient tumor therapy, and they also provide the possibility of eliminating CSCs. Therefore, this paper reviews the current carrier forms, targeting strategies, and therapeutic applications of nanodrug delivery systems (NDDS) implemented as a therapeutic option for CSCs. We also discuss the challenges and future research directions of NDDS for CSCs therapy.
引用
收藏
页数:14
相关论文
共 131 条
  • [1] Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
    Alhabbab, Rowa Y.
    [J]. FRONTIERS IN GENETICS, 2020, 11
  • [2] Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo
    Andrade, Fernanda
    Rafael, Diana
    Vilar-Hernandez, Mireia
    Montero, Sara
    Martinez-Trucharte, Francesc
    Seras-Franzoso, Joaquin
    Diaz-Riascos, Zamira, V
    Boullosa, Ana
    Garcia-Aranda, Natalia
    Camara-Sanchez, Patricia
    Arango, Diego
    Nestor, Marika
    Abasolo, Ibane
    Sarmento, Bruno
    Schwartz, Simo, Jr.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2021, 331 : 198 - 212
  • [3] The scrambled story between hyaluronan and glioblastoma
    Arturo Pibuel, Matias
    Poodts, Daniela
    Diaz, Mariangeles
    Elvira Hajos, Silvia
    Laura Lompardia, Silvina
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [4] Molecular Targeting of TRF2 Suppresses the Growth and Tumorigenesis of Glioblastoma Stem Cells
    Bai, Yun
    Lathia, Justin D.
    Zhang, Peisu
    Flavahan, William
    Rich, Jeremy N.
    Mattson, Mark P.
    [J]. GLIA, 2014, 62 (10) : 1687 - 1698
  • [5] Phenotyping and Target Expression Profiling of CD34+/CD38- and CD34+/CD38+Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
    Blatt, Katharina
    Menzl, Ingeborg
    Eisenwort, Gregor
    Cerny-Reiterer, Sabine
    Herrmann, Harald
    Herndlhofer, Susanne
    Stefanzl, Gabriele
    Sadovnik, Irina
    Berger, Daniela
    Keller, Alexandra
    Hauswirth, Alexander
    Hoermann, Gregor
    Willmann, Michael
    Rulicke, Thomas
    Sill, Heinz
    Sperr, Wolfgang R.
    Mannhalter, Christine
    Melo, Junia V.
    Jager, Ulrich
    Sexl, Veronika
    Valent, Peter
    [J]. NEOPLASIA, 2018, 20 (06): : 632 - 642
  • [6] Identification and Targeting of Stem Cell-Activated Pathways in Cancer Therapy
    Budillon, Alfredo
    Curley, Steven
    Fusco, Roberta
    Mancini, Rita
    [J]. STEM CELLS INTERNATIONAL, 2019, 2019
  • [7] Biodegradable hydrogel with thermo-response and hemostatic effect for photothermal enhanced anti-infective therapy
    Cao, Changyu
    Yang, Nan
    Zhao, Ye
    Yang, Dapeng
    Hu, Yanling
    Yang, Dongliang
    Song, Xuejiao
    Wang, Wenjun
    Dong, Xiaochen
    [J]. NANO TODAY, 2021, 39
  • [8] Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites
    Cao, Jun
    Huang, Dennis
    Peppas, Nicholas A.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2020, 167 : 170 - 188
  • [9] The promotion of nanoparticle delivery to two populations of gastric cancer stem cells by CD133 and CD44 antibodies
    Chen, Han
    Lin, Jiajia
    Shan, Yongqi
    Lu, Zhengmao
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 115
  • [10] Cancer Stemness Meets Immunity: From Mechanism to Therapy
    Chen, Peiwen
    Hsu, Wen-Hao
    Han, Jincheng
    Xia, Yan
    DePinho, Ronald A.
    [J]. CELL REPORTS, 2021, 34 (01):